Pharmaceutical Industry
Pick a topic, share experiences, and discover new perspectives.
Business, Economy & Finance
0
Tempus AI (TEM) Stock: Contract Value Tops $1.1 Billion as Pharma Giants Adopt AI Platform
Perspective:
Victoria Steel
Tempus AI’s total contract value surpassed $1.1 billion for the first time, driven by pharmaceutical companies adopting its AI-powered healthcare tools The company signed over 70 data agreements in 2025 with major drugmakers including AstraZeneca, GSK, Bristol Myers Squibb, Pfizer, and Merck Data and Applications segment revenue reached approximately $316 million for 2025.